Fahmeed Kazi

Fahmeed Kazi is an experienced professional in the biotech and quality assurance sectors, currently serving as Manager Biotech at Macter International Limited since March 2021. Prior experience includes a role as Scientific Officer at Treidlia Biovet, where successful scale-up and production of a cGMP quality inactivated whole virus vaccine for Pilchard Orthomyxovirus were achieved. Earlier positions include Quality Assurance Officer at GMP Connect, and various roles in quality assurance and microbiology at Australian Biotechnologies and 3M Health Care. Fahmeed Kazi began a career in academia as a Chemistry Demonstrator at the University of Western Sydney. Educational qualifications comprise a Bachelor of Science (Honours) in Molecular Biotechnology from Western Sydney University and a student exchange experience at the University of Florida in Microbiology and Cell Science.